311 related articles for article (PubMed ID: 27697758)
1. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
2. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
3. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
4. Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Sutanto I; Soebandrio A; Ekawati LL; Chand K; Noviyanti R; Satyagraha AW; Subekti D; Santy YW; Crenna-Darusallam C; Instiaty I; Budiman W; Prasetya CB; Lardo S; Elyazar I; Duparc S; Cedar E; Rolfe K; Fernando D; Berni A; Jones S; Kleim JP; Fletcher K; Sharma H; Martin A; Taylor M; Goyal N; Green JA; Tan LK; Baird JK
Lancet Infect Dis; 2023 Oct; 23(10):1153-1163. PubMed ID: 37236221
[TBL] [Abstract][Full Text] [Related]
5. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects.
Lefèvre G; Carpenter P; Souppart C; Schmidli H; Martin JM; Lane A; Ward C; Amakye D
J Clin Pharmacol; 2002 Oct; 42(10):1147-58. PubMed ID: 12362930
[TBL] [Abstract][Full Text] [Related]
6. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
8. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
German P; Parikh S; Lawrence J; Dorsey G; Rosenthal PJ; Havlir D; Charlebois E; Hanpithakpong W; Lindegardh N; Aweeka FT
J Acquir Immune Defic Syndr; 2009 Aug; 51(4):424-9. PubMed ID: 19506482
[TBL] [Abstract][Full Text] [Related]
9. A trial of combination antimalarial therapies in children from Papua New Guinea.
Karunajeewa HA; Mueller I; Senn M; Lin E; Law I; Gomorrai PS; Oa O; Griffin S; Kotab K; Suano P; Tarongka N; Ura A; Lautu D; Page-Sharp M; Wong R; Salman S; Siba P; Ilett KF; Davis TM
N Engl J Med; 2008 Dec; 359(24):2545-57. PubMed ID: 19064624
[TBL] [Abstract][Full Text] [Related]
10. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
Nyunt MM; Nguyen VK; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Mwima MW; Achan J; Aweeka F; Parikh S; Mwebaza N
Antimicrob Agents Chemother; 2015 Dec; 60(3):1274-82. PubMed ID: 26666942
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
Staehli Hodel EM; Guidi M; Zanolari B; Mercier T; Duong S; Kabanywanyi AM; Ariey F; Buclin T; Beck HP; Decosterd LA; Olliaro P; Genton B; Csajka C
Malar J; 2013 Jul; 12():235. PubMed ID: 23841950
[TBL] [Abstract][Full Text] [Related]
12. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
[TBL] [Abstract][Full Text] [Related]
13. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
Kakuda TN; DeMasi R; van Delft Y; Mohammed P
HIV Med; 2013 Aug; 14(7):421-9. PubMed ID: 23441978
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
Menan H; Faye O; Same-Ekobo A; Oga AS; Faye B; Kiki Barro CP; Kuete T; N'diaye JL; Vicky AM; Tine R; Yavo W; Kane D; Kassi KF; Kone M
Malar J; 2011 Jul; 10():185. PubMed ID: 21740570
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
17. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Dow GS; Gettayacamin M; Hansukjariya P; Imerbsin R; Komcharoen S; Sattabongkot J; Kyle D; Milhous W; Cozens S; Kenworthy D; Miller A; Veazey J; Ohrt C
Malar J; 2011 Jul; 10():212. PubMed ID: 21801400
[TBL] [Abstract][Full Text] [Related]
18. Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.
Kredo T; Mauff K; Van der Walt JS; Wiesner L; Maartens G; Cohen K; Smith P; Barnes KI
Antimicrob Agents Chemother; 2011 Dec; 55(12):5616-23. PubMed ID: 21947399
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
Lefèvre G; Carpenter P; Souppart C; Schmidli H; McClean M; Stypinski D
Br J Clin Pharmacol; 2002 Nov; 54(5):485-92. PubMed ID: 12445027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]